WCCT’s Clinical Pharmacology Unit: Virtual Tour (Not Used)
WCCT’s Clinical Pharmacology Unit: Virtual Tour In light of the current COVID-19 pandemic, WCCT Global is doing its part to maintain staff and subject safety by limiting the number of [...]
10 Questions to Ask Clinical Phase 1 Units During Site Selection
It’s becoming more and more common for Sponsors and CROs to establish shortlists or preferred providers, even for Clinical Phase 1 Units. When this happens, the site selection and site [...]
WCCT’s General Capabilities in Early Phase Clinical Trials
WCCT’s General Capabilities in Early Phase Clinical Trials As an early phase CRO specializing in Phase 1 and 2 clinical trials, WCCT Global has a range of capabilities in the pharmaceutical and [...]
The Future of Cannabis Clinical Research and Medicine
Current Landscape of Cannabis Clinical Research As it stands, cannabis is classified as a Schedule 1 drug by the Drug Enforcement Agency (DEA). According to the DEA, a drug is classified as [...]
When Your Phase 1 Clinical Trial Unit Receives an FDA 483, What Then?
At some point or another, every Phase 1 clinical trial unit has or will receive a 483 from the FDA. Before we delve into what this means for a site, we’ll provide a bit of background. When are [...]